Medifast (MED) Stock Price, News & Analysis

Company Overview

Medifast, Inc. (NYSE: MED) is a health and wellness company that provides weight-management products, programs and support services. Its primary brand, OPTAVIA, offers meal-replacement products, including shakes, bars, soups and other portion-controlled foods, along with structured plans intended to help customers establish healthier eating and lifestyle habits.

The company distributes its products primarily through an independent network of coaches who provide guidance, accountability and support to clients. Medifast’s offerings are marketed mainly to consumers in the United States, with an emphasis on combining nutrition products with coaching and behavior-change programs.

Founded in 1980, Medifast has historically operated through a direct-to-consumer and direct-selling model. The company introduced the OPTAVIA brand in 2017, expanding its focus from individual weight-loss products to integrated programs that pair food products with coaching and ongoing client support.

Key Stats

• Today's Range: $12.20 to $12.93
• 50-Day Range: $11.30 to $12.66
• 52-Week Range: $9.22 to $13.45
• Volume: 113,649 shs
• Average Volume: 206,721 shs
• Market Capitalization: $140.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.00
• Consensus Rating: Hold

Medifast Stock Analysis - MarketRank™

Medifast scored higher than 30% of companies evaluated by MarketBeat, and ranked 141st out of 170 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.6 / 5
• Analyst Rating: Hold

Consensus Rating

Medifast has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, no buy ratings, 1 hold rating, and 1 sell rating.

Downside Risk

Medifast has a consensus price target of $12.00, representing about 5.5% downside from its current price of $12.70.

Amount of Analyst Coverage

Medifast has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Medifast are expected to grow in the coming year, from ($1.04) to ($0.47) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medifast is -5.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medifast is -5.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Medifast has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

10.75% of the float of Medifast has been sold short.

Short Interest Ratio / Days to Cover

Medifast has a short interest ratio ("days to cover") of 11.36, which indicates bearish sentiment.

Change versus previous month

Short interest in Medifast has recently increased by 9.91%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medifast does not currently pay a dividend.

Dividend Growth

Medifast does not have a long track record of dividend growth.

News and Social Media

• Score: 2.6 / 5
• News Sentiment: 0.09

News Sentiment

Medifast has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 16 news articles for Medifast this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

2 people have added Medifast to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 3.7 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $1,197,276.00 in company stock, which represents 0.8432% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Medifast insiders have bought 529.07% more of their company's stock than they have sold. Specifically, they have bought $1,423,576.00 in company stock and sold $226,300.00 in company stock.

Percentage Held by Insiders

3.70% of the stock of Medifast is held by insiders.

Percentage Held by Institutions

95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 10/26/2026
• Today: 10/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Staples
• Industry: Personal Care Products
• Sub-Industry: Personal Care Products
• Current Symbol: NYSE:MED
• CIK: 910329
• Web: www.medifastinc.com
• Phone: (410) 581-8042
• Fax: 410-581-8070
• Employees: 380
• Year Founded: 1981

Price Target and Rating

• Average Price Target for Medifast: $12.00
• High Price Target: $12.00
• Low Price Target: $12.00
• Potential Upside/Downside: -4.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.33)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$18.67 million
• Net Margins: -8.08%
• Pretax Margin: -4.41%
• Return on Equity: -6.69%
• Return on Assets: -5.25%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.86
• Quick Ratio: 4.35

Sales & Book Value

• Annual Sales: $385.79 million
• Price / Sales: 0.36
• Cash Flow: $0.44 per share
• Price / Cash Flow: 28.60
• Book Value: $18.10 per share
• Price / Book: 0.69

Miscellaneous

• Outstanding Shares: 11,180,000
• Free Float: 10,767,000
• Market Cap: $140.25 million
• Optionable: Optionable
• Beta: 0.68